couchbase - BASE
BASE
Close Chg Chg %
14.66 1.01 6.89%
Closed Market
15.67
+1.01 (6.89%)
Volume: 2.06M
Last Updated:
Mar 28, 2025, 4:00 PM EDT
Company Overview: couchbase - BASE
BASE Key Data
| Open $14.60 | Day Range 14.60 - 15.85 |
| 52 Week Range 12.92 - 28.67 | Market Cap $778.45M |
| Shares Outstanding 53.10M | Public Float 40.23M |
| Beta 0.81 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$1.46 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.08M |
BASE Performance
| 1 Week | 8.29% | ||
| 1 Month | -11.22% | ||
| 3 Months | 2.82% | ||
| 1 Year | -40.44% | ||
| 5 Years | N/A |
BASE Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
16
Full Ratings ➔
About couchbase - BASE
Couchbase, Inc. engages in the development of document database management solutions. It offers its Couchbase platform to developers to build enterprise web, mobile, and Internet of things applications that support massive data volumes in real time. The company was founded by Phillips James, Dustin Sallings, Damien Katz, Jan Lehnardt, Phillips James, and J. Chris Anderson in 2008, and is headquartered in Santa Clara, CA.
BASE At a Glance
Couchbase, Inc.
3250 Olcott Street
Santa Clara, California 95054
| Phone | 1-650-417-7500 | Revenue | 209.47M | |
| Industry | Packaged Software | Net Income | -74,653,000.00 | |
| Sector | Technology Services | 2025 Sales Growth | 16.346% | |
| Fiscal Year-end | 01 / 2026 | Employees | 792 | |
| View SEC Filings |
BASE Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 4.346 |
| Price to Book Ratio | 7.379 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -10.048 |
| Enterprise Value to Sales | 3.664 |
| Total Debt to Enterprise Value | 0.006 |
BASE Efficiency
| Revenue/Employee | 264,477.273 |
| Income Per Employee | -94,258.838 |
| Receivables Turnover | 4.254 |
| Total Asset Turnover | 0.824 |
BASE Liquidity
| Current Ratio | 1.662 |
| Quick Ratio | 1.662 |
| Cash Ratio | 1.156 |
BASE Profitability
| Gross Margin | 88.084 |
| Operating Margin | -37.55 |
| Pretax Margin | -34.779 |
| Net Margin | -35.64 |
| Return on Assets | -29.371 |
| Return on Equity | -57.862 |
| Return on Total Capital | -56.584 |
| Return on Invested Capital | -56.754 |
BASE Capital Structure
| Total Debt to Total Equity | 3.382 |
| Total Debt to Total Capital | 3.271 |
| Total Debt to Total Assets | 1.656 |
| Long-Term Debt to Equity | 2.319 |
| Long-Term Debt to Total Capital | 2.244 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Couchbase - BASE
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 123.54M | 154.82M | 180.04M | 209.47M | |
Sales Growth
| +19.61% | +25.32% | +16.28% | +16.35% | |
Cost of Goods Sold (COGS) incl D&A
| 14.78M | 20.26M | 22.08M | 24.96M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 2.82M | 6.08M | 2.42M | 2.28M | |
Depreciation
| 2.82M | 6.08M | 2.42M | 2.28M | |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| +27.24% | +37.06% | +9.00% | +13.03% | |
Gross Income
| 108.76M | 134.56M | 157.96M | 184.51M | |
Gross Income Growth
| +18.65% | +23.73% | +17.38% | +16.81% | |
Gross Profit Margin
| +88.04% | +86.91% | +87.73% | +88.08% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 165.02M | 202.22M | 237.29M | 263.16M | |
Research & Development
| 51.64M | 57.76M | 64.07M | 70.58M | |
Other SG&A
| 113.38M | 144.46M | 173.22M | 192.59M | |
SGA Growth
| +32.28% | +22.54% | +17.34% | +10.90% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | 1.66M | 5.20M | - |
EBIT after Unusual Expense
| (56.26M) | (69.31M) | (84.54M) | (78.66M) | |
Non Operating Income/Expense
| (300.00K) | 1.96M | 5.75M | 5.86M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 656.00K | 101.00K | 43.00K | 60.00K | |
Interest Expense Growth
| -90.59% | -84.60% | -57.43% | +39.53% | |
Gross Interest Expense
| 656.00K | 101.00K | 43.00K | 60.00K | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (57.21M) | (67.46M) | (78.83M) | (72.85M) | |
Pretax Income Growth
| -46.93% | -17.90% | -16.86% | +7.58% | |
Pretax Margin
| -46.31% | -43.57% | -43.78% | -34.78% | |
Income Tax
| 1.01M | 1.04M | 1.35M | 1.80M | |
Income Tax - Current - Domestic
| 58.00K | 65.00K | 105.00K | 100.00K | |
Income Tax - Current - Foreign
| 957.00K | 1.46M | 1.35M | 1.79M | |
Income Tax - Deferred - Domestic
| - | - | - | - | - |
Income Tax - Deferred - Foreign
| - | (486.00K) | (101.00K) | (92.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (58.23M) | (68.49M) | (80.18M) | (74.65M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (58.23M) | (68.49M) | (80.18M) | (74.65M) | |
Net Income Growth
| -45.63% | -17.63% | -17.07% | +6.90% | |
Net Margin Growth
| -47.13% | -44.24% | -44.54% | -35.64% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (58.23M) | (68.49M) | (80.18M) | (74.65M) | |
Preferred Dividends
| - | - | - | 2.92M | - |
Net Income Available to Common
| (61.15M) | (68.49M) | (80.18M) | (74.65M) | |
EPS (Basic)
| -1.3945 | -1.5293 | -1.6997 | -1.4549 | |
EPS (Basic) Growth
| -26.83% | -9.67% | -11.14% | +14.40% | |
Basic Shares Outstanding
| 43.85M | 44.79M | 47.17M | 51.31M | |
EPS (Diluted)
| -1.3945 | -1.5293 | -1.6997 | -1.4549 | |
EPS (Diluted) Growth
| -26.83% | -9.67% | -11.14% | +14.40% | |
Diluted Shares Outstanding
| 43.85M | 44.79M | 47.17M | 51.31M | |
EBITDA
| (53.43M) | (61.57M) | (76.91M) | (76.38M) | |
EBITDA Growth
| -71.96% | -15.23% | -24.91% | +0.70% | |
EBITDA Margin
| -43.25% | -39.77% | -42.72% | -36.46% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 21.867 | |
| Number of Ratings | 16 | Current Quarters Estimate | -0.078 | |
| FY Report Date | 04 / 2025 | Current Year's Estimate | -0.14 | |
| Last Quarter’s Earnings | -0.02 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.20 | Next Fiscal Year Estimate | 0.057 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 15 | 15 | 15 | 14 |
| Mean Estimate | -0.08 | -0.05 | -0.14 | 0.06 |
| High Estimates | -0.06 | -0.01 | -0.08 | 0.13 |
| Low Estimate | -0.09 | -0.09 | -0.18 | -0.01 |
| Coefficient of Variance | -14.21 | -38.03 | -26.16 | 71.16 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 11 | 11 | 11 |
| OVERWEIGHT | 2 | 2 | 2 |
| HOLD | 2 | 2 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Couchbase - BASE
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Couchbase - BASE
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 25, 2025 | Margaret Chow SVP & Chief Legal Officer | 205,175 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $14 per share | 2,872,450.00 |
| Mar 24, 2025 | Jeffrey E. Epstein Director | 79,650 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $5.15 per share | 410,197.50 |
| Mar 24, 2025 | Jeffrey E. Epstein Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 21, 2025 | Edward Thomas Anderson Director | 87,177 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 21, 2025 | Matthew M. Cain Chair, President, and CEO; Director | 996,282 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.55 per share | 13,499,621.10 |
| Mar 21, 2025 | Richard A. Simonson Director | 40,047 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 21, 2025 | Huw Owen SVP & Chief Revenue Officer | 443,637 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.55 per share | 6,011,281.35 |
| Mar 21, 2025 | William Robert Carey Interim CFO & CAO | 97,080 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.55 per share | 1,315,434.00 |
| Mar 21, 2025 | Lynn Christensen Director | 9,689 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 21, 2025 | Aleksander J. Migon Director | 34,963 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Carol Wang Carpenter Director | 19,927 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17.65 per share | 351,711.55 |
| Jun 25, 2024 | Gregory Nathaniel Henry SVP & Chief Financial Officer | 393,060 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $16.52 per share | 6,493,351.20 |
| Jun 25, 2024 | Huw Owen SVP & Chief Revenue Officer | 405,123 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $16.84 per share | 6,822,271.32 |
| Jun 6, 2024 | Matthew M. Cain Chair, President, and CEO; Director | 855,304 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.74 per share | 19,449,612.96 |
| Jun 4, 2024 | Alvina Y. Antar Director | 37,668 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 4, 2024 | David C. Scott Director | 28,027 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 4, 2024 | Kevin J. Efrusy Director | 28,027 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 22, 2024 | Margaret Chow SVP & Chief Legal Officer | 137,999 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 22, 2024 | Margaret Chow SVP & Chief Legal Officer | 139,065 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 22, 2024 | Margaret Chow SVP & Chief Legal Officer | 211,495 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $7.75 per share | 1,639,086.25 |
Couchbase in the News
Krispy Kreme being added to Russell 2000
Krispy Kreme announced Monday that the donut-maker is being added to the Russell 2000.